wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26852388-A31EB149-6FEE-4271-A37F-C9E4C886DE24
Q26852388-A31EB149-6FEE-4271-A37F-C9E4C886DE24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26852388-A31EB149-6FEE-4271-A37F-C9E4C886DE24
Immunotherapy for prostate cancer: recent developments and future challenges
P2860
Q26852388-A31EB149-6FEE-4271-A37F-C9E4C886DE24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26852388-A31EB149-6FEE-4271-A37F-C9E4C886DE24
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
119c816a6505c42e62d39209f7778898f89e76d5
P2860
Tumor-specific CD4+ T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity